Intraspinal MDL28170 microinjection improves functional and pathological outcome following spinal cord injury

Journal of Neurotrauma

Volumn 25, Issue 7, 2008, Pages 833-840

  Yu, Chen Guang ^a   Joshi, Aashish ^a   Geddes, James W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Locomotion; Neurodegeneration; Neuroprotection; White matter sparing

Indexed keywords

[1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONTUSION; EVALUATION; FEMALE; HISTOLOGY; LOCOMOTION; LONG EVANS RAT; MICROINJECTION; NONHUMAN; OPEN FIELD BEHAVIOR; OUTCOME ASSESSMENT; RAT; SINGLE DRUG DOSE; SPINAL CORD; SPINAL CORD FUNCTION; SPINAL CORD INJURY;

ANIMALS; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; DISEASE MODELS, ANIMAL; FEMALE; MICROINJECTIONS; MOTOR ACTIVITY; MOVEMENT DISORDERS; NERVE FIBERS, MYELINATED; RATS; RATS, LONG-EVANS; SPINAL CORD; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 48249117463     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2007.0490     Document Type: Article

References (45)

1. Arataki, S., Tomizawa, K., Moriwaki, A., Nishida, K., Matsushita, M., Ozaki, T., Kunisada, T., Yoshida, A., Inoue, H., and Matsui, H. (2005). Calpain inhibitors prevent neuronal cell death and ameliorate motor disturbances after compression-induced spinal cord injury in rats. J. Neurotrauma 22, 398-406.
2. Banik, N.L., Hogan, E.L., and Mcalhaney, W.W. (1984). A role for calcium and activation of neutral proteinase in myelinolysis? Prog. Clin. Biol. Res. 146, 145-152.
3. Banik, N.L., Hogan, E.L., Powers, J.M., and Smith, K.P. (1986). Proteolytic enzymes in experimental spinal cord injury. J. Neurol. Sci. 73, 245-256.
4. Banik, N.L., Matzelle, D.C., Gantt-Wilford, G., Osborne, A., and Hogan, E.L. (1997). Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752, 301-306.
5. + exchanger in excitotoxicity. Cell 120, 275-285.
6. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1996). Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
7. Blight, A.R. (1983). Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience 10, 521-543.
8. Brorson, J.R., Marcuccilli, C.J., and Miller, R.J. (1995). Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26, 1259-1267.
9. Cuerrier, D., Moldoveanu, T., Campbell, R.L., Kelly, J., Yoruk, B., Verhelst, S.H., Greenbaum, D., Bogyo, M., and Davies, P.L. (2007). Development of calpain-specific inactivators by screening of positional scanning epoxide libraries. J. Biol. Chem. 282, 9600-9611.
10. Cuzzocrea, S., Mcdonald, M.C., Mazzon, E., Siriwardena, D., Serraino, I., Dugo, L., Britti, D., Mazzullo, G., Caputi, A.P., and Thiemermann, C. (2000). Calpain inhibitor I reduces the development of acute and chronic inflammation. Am. J. Pathol. 157, 2065-2079.
11. Das, A., Sribnick, E.A., Wingrave, J.M., Del Re, A.M., Woodward, J.J., Appel, S.H., Banik, N.L., and Ray, S.K. (2005). Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J. Neurosci. Res. 81, 551-562.
12. Hung, K.S., Hwang, S.L., Liang, C.L., Chen, Y.J., Lee, T.H., Liu, J.K., Howng, S.L., and Wang, C.H. (2005). Calpain inhibitor inhibits p35-p25-Cdk5 activation, decreases tau hyperphosphorylation, and improves neurological function after spinal cord hemisection in rats. J. Neuropathol. Exp. Neurol. 64, 15-26.
13. James, T., Matzelle, D., Bartus, R., Hogan, E.L., and Banik, N.L. (1998). New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro. J. Neurosci. Res. 51, 218-222.
14. Kieran, D., and Greensmith, L. (2004). Inhibition of calpains, by treatment with leupeptin, improves motoneuron survival and muscle function in models of motoneuron degeneration. Neuroscience 125, 427-439.
15. Kupina, N.C., Nath, R., Bernath, E.E., Inoue, J., Mitsuyoshi, A., Yuen, P.W., Wang, K.K., and Hall, E.D. (2001). The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J. Neurotrauma 18, 1229-1240.
16. Magnuson, D.S., Trinder, T.C., Zhang, Y.P., Burke, D., Morassutti, D.J., and Shields, C.B. (1999). Comparing deficits following excitotoxic and contusion injuries in the thoracic and lumbar spinal cord of the adult rat. Exp. Neurol. 156, 191-204.
17. Majczynski, H., Maleszak, K., Gorska, T., and Slawinska, U. (2007). Comparison of two methods for quantitative assessment of unrestrained locomotion in the rat. J. Neurosci. Methods 163, 197-207.
18. Momeni, H.R., and Kanje, M. (2005). The calpain inhibitor VI prevents apoptosis of adult motor neurons. Neuroreport 16, 1065-1068.
19. Moore, J.D., Rothwell, N.J., and Gibson, R.M. (2002). Involvement of caspases and calpains in cerebrocortical neuronal cell death is stimulus-dependent. Br. J. Pharmacol. 135, 1069-1077.
20. Neffe, A.T., and Abell, A.D. (2005). Developments in the design and synthesis of calpain inhibitors. Curr. Opin. Drug Discov. Dev. 8, 684-700.
21. O'hanlon, G.M., Humphreys, P.D., Goldman, R.S., Halstead, S.K., Bullens, R.W., Plomp, J.J., Ushkaryov, Y., and Willison, H.J. (2003). Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain 126, 2497-2509.
22. Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R.J., and Sonenshein, G.E. (2001). Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 20, 1287-1299.
23. Rabchevsky, A.G., Fugaccia, I., Sullivan, P.G., and Scheff, S.W. (2001). Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J. Neurotrauma 18, 513-522.
24. Ray, S.K., Hogan, E.L., and Banik, N.L. (2003). Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res. Brain Res. Rev. 42, 169-185.
25. Ray, S.K., Neuberger, T.J., Deadwyler, G., Wilford, G., Devries, G.H., and Banik, N.L. (2002). Calpain and calpastatin expression in primary oligodendrocyte culture: preferential localization of membrane calpain in cell processes. J. Neurosci. Res. 70, 561-569.
26. Ray, S.K., Shields, D.C., Saido, T.C., Matzelle, D.C., Wilford, G.G., Hogan, E.L., and Banik, N.L. (1999). Calpain activity and translational expression increased in spinal cord injury. Brain Res. 816, 375-380.
27. Rock, M.T., Dix, A.R., Brooks, W.H., and Roszman, T.L. (2000). Beta1 integrin-mediated T cell adhesion and cell spreading are regulated by calpain. Exp. Cell Res. 261, 260-270.
28. Saatman, K.E., Zhang, C., Bartus, R.T., and Mcintosh, T.K. (2000). Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis. J. Cereb. Blood Flow Metab. 20, 66-73.
29. Sanders, M.L., and Donkor, I.O. (2006). A novel series of urea-based peptidomimetic calpain inhibitors. Bioorg. Med. Chem. Lett. 16, 1965-1968.
30. Schaecher, K.E., Shields, D.C., and Banik, N.L. (2001). Mechanism of myelin breakdown in experimental demyelination: a putative role for calpain. Neurochem. Res. 26, 731-737.
31. Schaub, F.J., Liles, W.C., Ferri, N., Sayson, K., Seifert, R.A., and Bowen-Pope, D.F. (2003). Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase-and calpain-dependent release of interleukin-1alpha. Circ. Res. 93, 515-522.
32. Scheff, S.W., Rabchevsky, A.G., Fugaccia, I., Main, J.A., and Lumpp, J.E., Jr. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179-193.
33. Schumacher, P.A., Eubanks, J.H., and Fehlings, M.G. (1999). Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury. Neuroscience 91, 733-744.
34. Schumacher, P.A., Siman, R.G., and Fehlings, M.G. (2000). Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J. Neurochem. 74, 1646-1655.
35. Shields, D.C., Schaecher, K.E., Hogan, E.L., and Banik, N.L. (2000). Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J. Neurosci. Res. 61, 146-150.
36. Springer, J.E., Azbill, R.D., Kennedy, S.E., George, J., and Geddes, J.W. (1997). Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J. Neurochem. 69, 1592-1600.
37. 2+-dependent protease, calpain. J. Cell Biol. 140, 699-707.
38. Teng, Y.D., and Wrathall, J.R. (1997). Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury. J. Neurosci. 17, 4359-4366.
39. Wang, K.K. (1990). Developing selective inhibitors of calpain. Trends Pharmacol. Sci. 11, 139-142.
40. Wang, K.K., and Yuen, P.W. (1997). Development and therapeutic potential of calpain inhibitors. Adv. Pharmacol. 37, 117-152.
41. Watanabe, N., and Kobayashi, Y. (1994). Selective release of a processed form of interleukin 1 alpha. Cytokine 6, 597-601.
42. Yu, C.G., and Geddes, J.W. (2007). Sustained calpain inhibition improves locomotor function and tissue sparing following contusive spinal cord injury. Neurochem. Res. 32, 2046-2053.
43. Yu, C.G., Marcillo, A.E., Fairbanks, C.A., Wilcox, G.L., and Yezierski, R.P. (2000). Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport 11, 3203-3207.
44. Zhang, S.X., Bondada, V., and Geddes, J.W. (2003). Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection. J. Neurotrauma 20, 59-67.
45. Zhang, S.X., Underwood, M., Landfield, A., Huang, F.F., Gison, S., and Geddes, J.W. (2000). Cytoskeletal disruption following contusion injury to the rat spinal cord. J. Neuropathol. Exp. Neurol. 59, 287-296.